Terminated PHASE2 INTERVENTIONAL 2-arm NCT00937768

Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Phase II Trial of Temporary Androgen Deprivation Therapy in High Risk Prostate Cancer Following Radical Prostatectomy

Sponsor: Mayo Clinic

Conditions Prostate Adenocarcinoma Stage IIA Prostate Cancer Stage IIB Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer

Interventions Goserelin Acetate Laboratory Biomarker Analysis Leuprolide Acetate Quality-of-Life Assessment

Updated 7 times since 2017 Last updated: Dec 9, 2019 Started: Jul 31, 2009 Primary completion: Jun 30, 2012 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Mayo Clinic

See all terminations from Mayo Clinic

Other Prostate Adenocarcinoma trials with similar outcome

Browse all Prostate Adenocarcinoma trials

A PHASE2 clinical study on Prostate Adenocarcinoma and Stage IIA Prostate Cancer, this trial is terminated or withdrawn. The trial is conducted by Mayo Clinic and has accumulated 7 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2020 — Jan 2021 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2020 [monthly]

Terminated PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic
National Cancer Institute (NCI)

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States